← All diseases
Cancer
Liver cancer
Do you want to receive a message when there is new research about Liver cancer? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence above each publication explains what was studied — and you'll be notified as soon as new research on Liver cancer is available. View what Premium costs.
Publications and studies (3377)
- HCC Model Induced by P53 and Pten Knockout in HBV Transgenic Mice Mirrors Human HCC at the Transcriptome Level. (2024/12/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Toxicity Effect of Hypnea flagelliformis Algae on Cancerous Mitochondria Obtained from Rat Model of Hepatocellular Carcinoma. (2024/12/01) ♡
- A New Approach to Analysis of Clinical Data and Prognostication for Patients with Hepatocellular Carcinoma, Based Upon a Network Phenotyping Strategy (NPS) Computational Method. (2024/12/01) ♡
- Suppression of popping rates in radiofrequency ablation under perfluorobutane microbubbles for hepatocellular carcinoma. (2024/12/01) ♡
- Blocking interleukin-1 receptor type 1 (IL-1R1) signaling in hepatocytes slows down diethylnitrosamine-induced liver tumor growth in obese mice. (2024/11/29) ♡
- Sexual dimorphism or MASLD-driven bone loss. (2024/11/28) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Alcohol-related liver disease (ALD): current perspectives on pathogenesis, therapeutic strategies, and animal models. (2024/11/28) ♡
- Exploring the therapeutic potential of Emblica officinalis natural compounds against hepatocellular carcinoma (HCC): a computational approach. (2024/11/26) ♡
- TAT as a new marker and its use for noninvasive chemical biopsy in NASH diagnosis. (2024/11/26) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Metabolic Dysfunction-Associated Steatotic Liver Disease in Chronic Hepatitis C Virus Infection: From Basics to Clinical and Nutritional Management. (2024/11/24) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Non-invasive biomarkers implicated in urea and TCA cycles for metabolic liver disease. (2024/11/22) ♡
- Development of hepatocellular carcinoma organoid model recapitulating HIF-1A metabolic signature. (2024/11/21) ♡
- Therapeutic Glypican-3 CRISPR Genome-Editing Using UltraLarge Porous Silica Nano-Depot for the Treatment of Hepatocellular Carcinoma. (2024/11/21) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Immunometabolic Targets in CD8 (+) T Cells within the Tumor Microenvironment of Hepatocellular Carcinoma. (2024/11/21) ♡
- Smart Mesoporous Silica Nanoparticles Loading Curcumin Inhibit Liver Cancer. (2024/11/20) ♡
- In-silico studies on evaluating the liver-protective effectiveness of a polyherbal formulation in preventing hepatocellular carcinoma progression. (2024/11/19) ♡
- Babaodan inhibits cell proliferation and metastasis and enhances anti-tumor effects of camrelizumab by inhibiting M2 phenotype macrophages in hepatocellular carcinoma. (2024/11/15) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. D-glucaro-1,4-lactone improves Diethylnitrosamine-induced hepatocellular carcinoma in rats via the uric acid-ROS pathway. (2024/11/15) ♡
- Effects of resveratrol-loaded dendrimer nanomedicine on hepatocellular carcinoma cells. (2024/11/14) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease. (2024/11/14) ♡
- First-Line Lenvatinib plus Pembrolizumab for Hepatocellular Carcinoma: Post hoc Analysis of Japanese Patients from the Phase 3 LEAP-002 Trial. (2024/11/14) ♡
- Comprehensive Analysis of Radiologic Cancer-Free Status through Various Treatment Approaches in Advanced-Stage Hepatocellular Carcinoma. (2024/11/13) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Demographics and Immunotherapy Efficacy for Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Phase III Clinical Trials. (2024/11/13) ♡
- Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Features Can Predict Immune-Excluded Phenotype of Hepatocellular Carcinoma. (2024/11/13) ♡
- PRMT1-mediated methylation of ME2 promotes hepatocellular carcinoma growth by inhibiting ubiquitination. (2024/11/11) ♡
- Targeting SPP1-orchestrated neutrophil extracellular traps-dominant pre-metastatic niche reduced HCC lung metastasis. (2024/11/11) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Beyond the Liver: A Comprehensive Review of Strategies to Prevent Hepatocellular Carcinoma. (2024/11/11) ♡
- Establishment and characterization of mouse metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma organoids. (2024/11/10) ♡
- Exploring causal associations between dietary intake and liver diseases: A bidirectional Mendelian randomization study. (2024/11/08) ♡
- The correlation between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) with non-alcoholic fatty liver disease: an analysis of the population-based NHANES (2017-2018). (2024/11/08) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. PAMK Ameliorates Non-Alcoholic Steatohepatitis and Associated Anxiety/Depression-like Behaviors Through Restoring Gut Microbiota and Metabolites in Mice. (2024/11/08) ♡
- Comment on “Clinical outcomes and histologic findings of patients with hepatocellular carcinoma with durable partial response or durable stable disease after receiving atezolizumab plus bevacizumab”. (2024/11/07) ♡
- Yangzheng mixture reversed EMT against hepatocellular carcinoma metastasis via NF-κb/NLRP3/β-catenin pathway. (2024/11/06) ♡
- Early-life antibiotic exposure aggravate the metabolic dysfunction-associated steatotic liver disease associated hepatocellular carcinoma. (2024/11/06) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Double-Edge Effects of Leucine on Cancer Cells. (2024/11/04) ♡
- β, β-Dimethylacrylalkannin, a key component of Zicao, induces cell cycle arrest and necrosis in hepatocellular carcinoma cells. (2024/11/01) ♡
- Atractylodes Lancea and Its Constituent, Atractylodin, Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease via AMPK Activation. (2024/11/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Inhibition of hepatic stellate cell activation by nutraceuticals: an emphasis on mechanisms of action. (2024/11/01) ♡
- Jiedu recipe, a compound Chinese herbal medicine, suppresses hepatocellular carcinoma metastasis by inhibiting the release of tumor-derived exosomes in a hypoxic microenvironment. (2024/11/01) ♡
- Therapeutic potential of Solanum surattense against hepatitis C virus in liver hepatoma cells. (2024/11/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Hepatocellular Carcinoma: Molecular Diagnosis and Perspectives for Therapy. (2024/11/01) ♡
- Qizhu anticancer prescription enhances immunosurveillance of liver cancer cells by regulating p21-dependent secretory phenotypes. (2024/10/28) ♡
- Prognostic relevance of sarcopenia and tumor-infiltrating CD8 (+) T cells in patients with hepatocellular carcinoma (2024/10/26) ♡
- Rifaximin prophylaxis in MASLD hepatocellular carcinoma: Lessons from a negative animal model. (2024/10/24) ♡
- Kadukkai maathirai (Indian herbal drug) prevents hepatocellular cancer progression by enhancing GSTM1 expression and modulating β catenin transcription: in-silico and in-vivo study. (2024/10/22) ♡
- Glutathione and Selenium Supplementation Attenuates Liver Injury in Diethylnitrosamine-Induced Hepatocarcinogenic Mice by Enhancing Glutathione-Related Antioxidant Capacities. (2024/10/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Chinese Expert Consensus on the Whole-Course Management of Hepatocellular Carcinoma (2023 Edition). (2024/10/22) ♡
- Chinese Expert Consensus on the Combination of Targeted Therapy and Immunotherapy with Locoregional Therapy for Intermediate/Advanced Hepatocellular Carcinoma. (2024/10/21) ♡
- [Nlrp6 overexpression inhibits lipid synthesis to suppress proliferation of hepatocellular carcinoma cells by regulating the AMPK-srebp1c axis]. (2024/10/20) ♡
- Network pharmacology and bioinformatic integrative analysis reveals candidate gene targets and potential therapeutic of East Kalimantan propolis against hepatocellular carcinoma. (2024/10/19) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.